The Global ICAD (Intracranial Atherosclerotic Disease) Pathology market is expected to grow at a moderate rate during the forecast period. Growing awareness and demand for diagnosis of Intracranial Atherosclerotic Disease in the healthcare sector is boosting the growth of the global ICAD (Intracranial Atherosclerotic Disease) Pathology market. An increasing number of incidences of intracranial atherosclerotic disease will expand the growth of the market.
Moreover, governments in many countries are supporting and taking initiatives for the adoption of ICAD in the healthcare sector is the important factor expected to boost the growth of the ICAD (Intracranial Atherosclerotic Disease) Pathology market in near future. In addition to this, growing health care expenditure is further driving the expansion of this market globally.
On the other hand, a lack of awareness among patients and the high cost of diagnosis along with the challenges associated with the handling of instruments is likely to hamper the Global ICAD (Intracranial Atherosclerotic Disease) Pathology market during the forecast period.
Covid-19 Impact on ICAD (Intracranial Atherosclerotic Disease) Pathology Market:
In addition, the current ICAD (Intracranial Atherosclerotic Disease) Pathology Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the ICAD (Intracranial Atherosclerotic Disease) Pathology Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.
The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.
According to Type, the market is segmented into Stent, and PTA Balloon. Among these stent Authentication holds the largest share of the market mainly because stents offer major advantages than other devices while helping the healthcare professionals to manage the disease and surge in demand stents among healthcare professionals.
Based on application, the market is categorised into Hospital, Clinic, and Others. Furthermore, hospital segment are expected to grow at the highest rate in the coming years. Increasing adoption of advanced technologies for the management of the targeted disease in hospitals and surge in demand for early diagnosis of ICAD, which is boosting the demand for ICAD (Intracranial Atherosclerotic Disease) Pathology globally.
Market Analysis, Insights and Forecast – By Type · Stent · PTA Balloon
Market Analysis, Insights and Forecast – By Application · Hospital · Clinic · Others
Region-wise, North America dominated the Global ICAD (Intracranial Atherosclerotic Disease) Pathology market and is expected to continue its dominance during the forecast period. Factors such as the rising number of incidences of intracranial atherosclerotic disease and high health care expenditure propels the growth of the market in North America. Similarly, Asia Pacific is also expected to account for the fastest growth in the global market owing to well-established health care infrastructure. Factors such as development in the health care infrastructure, rising awareness about health, a surge in investment in diagnostic sectors, and growing adoption of advanced technologies available for ICAD are expected to escalate the growth of the ICAD (Intracranial Atherosclerotic Disease) Pathology market in the Asia Pacific region.
ICAD (Intracranial Atherosclerotic Disease) Pathology Market, By Geography
· North America (US & Canada) · Europe (UK, Germany, France, Italy, Spain, & Rest of Europe) · Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific) · LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
Some key developments and strategies adopted by manufacturers in the ICAD (Intracranial Atherosclerotic Disease) Pathology are highlighted below.
· In February 2021, the European Commission had approved, the acquisition of Varian Medical Systems by Siemens AG, through its subsidiary Siemens Healthineers. The approval is conditional on full compliance with the commitments offered by Siemens to ensure the interoperability of the companies' medical imaging and radiotherapy solutions with third-party solutions.